51 related articles for article (PubMed ID: 28627814)
1. The Soluble Urokinase-Type Plasminogen Activator Receptor as a Biomarker for Survival and Early Treatment Effect in Metastatic Colorectal Cancer.
Blomberg K; Hansen TF; Brasen CL; Madsen JB; Jensen LH; Thomsen CB
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680247
[TBL] [Abstract][Full Text] [Related]
2. ERAAs for menopause treatment: Welcome the 'designer estrogens'.
Hirsch HD; Shih E; Thacker HL
Cleve Clin J Med; 2017 Jun; 84(6):463-470. PubMed ID: 28628428
[TBL] [Abstract][Full Text] [Related]
3. Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Systemic Chronic Inflammation.
Rasmussen LJH; Petersen JEV; Eugen-Olsen J
Front Immunol; 2021; 12():780641. PubMed ID: 34925360
[TBL] [Abstract][Full Text] [Related]
4. A Preliminary Study of the Value of Plasma microRNA-193b and Soluble Urokinase-Type Plasminogen Activator Receptor in Identifying Patients with Early-Stage Colorectal Cancer and.
Liu KL; Luo JL; Wu J; Wang YD; Fan HJ
Clin Lab; 2017 Nov; 63(11):1949-1953. PubMed ID: 29226653
[TBL] [Abstract][Full Text] [Related]
5. Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin-treated breast cancer patients: a prospective exploratory study.
Chu J; Tung L; Atallah I; Wei C; Cobleigh M; Rao R; Feinstein SB; Usha L; Banach K; Reiser J; Okwuosa TM
Cardiooncology; 2024 Jan; 10(1):3. PubMed ID: 38225669
[TBL] [Abstract][Full Text] [Related]
6. suPARnostic: an advanced predictive tool for detecting recurrence in renal cell carcinoma.
Azawi N; Mosholt KSS; Fryd ND; Lund L; Brignone JI; Hvid N; Wulf-Johansson H; Pedersen OBV; Saekmose SG; Dabestani S
BMC Urol; 2023 Oct; 23(1):168. PubMed ID: 37875832
[TBL] [Abstract][Full Text] [Related]
7. High-throughput optofluidic screening of single B cells identifies novel cross-reactive antibodies as inhibitors of uPAR with antibody-dependent effector functions.
Lourenço AL; Chuo SW; Bohn MF; Hann B; Khan S; Yevalekar N; Patel N; Yang T; Xu L; Lv D; Drakas R; Lively S; Craik CS
MAbs; 2023; 15(1):2184197. PubMed ID: 36859773
[TBL] [Abstract][Full Text] [Related]
8. Association between variables measured in the ambulance and in-hospital mortality among adult patients with and without infection: a prospective cohort study.
Wallgren UM; Järnbert-Pettersson H; Sjölin J; Kurland L
BMC Emerg Med; 2022 Nov; 22(1):185. PubMed ID: 36418966
[TBL] [Abstract][Full Text] [Related]
9. A Role of the TEX101 Interactome in the Common Aetiology Behind Male Subfertility and Testicular Germ Cell Tumor.
Burton J; Wojewodzic MW; Rounge TB; Haugen TB
Front Oncol; 2022; 12():892043. PubMed ID: 35774118
[TBL] [Abstract][Full Text] [Related]
10. Soluble Urokinase Plasminogen Activator Receptor (suPAR) Independently Predicts Severity and Length of Hospitalisation in Patients With COVID-19.
Enocsson H; Idoff C; Gustafsson A; Govender M; Hopkins F; Larsson M; Nilsdotter-Augustinsson Å; Sjöwall J
Front Med (Lausanne); 2021; 8():791716. PubMed ID: 34926532
[No Abstract] [Full Text] [Related]
11. The Urokinase Receptor: A Multifunctional Receptor in Cancer Cell Biology. Therapeutic Implications.
Li Santi A; Napolitano F; Montuori N; Ragno P
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33923400
[TBL] [Abstract][Full Text] [Related]
12. Soluble urokinase-type plasminogen activator receptor (suPAR) is a risk indicator for eGFR loss in kidney transplant recipients.
Jehn U; Schütte-Nütgen K; Henke U; Pavenstädt H; Suwelack B; Reuter S
Sci Rep; 2021 Feb; 11(1):3713. PubMed ID: 33580120
[TBL] [Abstract][Full Text] [Related]
13. Cancer-associated hypersialylated MUC1 drives the differentiation of human monocytes into macrophages with a pathogenic phenotype.
Beatson R; Graham R; Grundland Freile F; Cozzetto D; Kannambath S; Pfeifer E; Woodman N; Owen J; Nuamah R; Mandel U; Pinder S; Gillett C; Noll T; Bouybayoune I; Taylor-Papadimitriou J; Burchell JM
Commun Biol; 2020 Nov; 3(1):644. PubMed ID: 33149188
[TBL] [Abstract][Full Text] [Related]
14. Role of the Glycosylphosphatidylinositol-Anchored Protein TEX101 and Its Related Molecules in Spermatogenesis.
Yoshitake H; Araki Y
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32927778
[TBL] [Abstract][Full Text] [Related]
15. Soluble Urokinase Plasminogen Activator Receptor (suPAR) Concentrations are Elevated in Patients with Neuroendocrine Malignancies.
Özdirik B; Stueven A; Knorr J; Geisler L; Mohr R; Demir M; Hellberg T; Loosen SH; Benz F; Wiedenmann B; Tacke F; Wree A; Jann H; Roderburg C
J Clin Med; 2020 May; 9(6):. PubMed ID: 32486367
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Role of Soluble Urokinase Plasminogen Activator Receptor at the Emergency Department: A Position Paper by the Hellenic Sepsis Study Group.
Velissaris D; Dimopoulos G; Parissis J; Alexiou Z; Antonakos N; Babalis D; Gerakari S; Kaldis V; Koutoukas P; Lada M; Leventogiannis K; Pantazopoulos I; Papadopoulos A; Polyzogopoulou E; Gogos C; Armaganidis A; Giamarellos-Bourboulis EJ
Infect Dis Ther; 2020 Sep; 9(3):407-416. PubMed ID: 32399855
[TBL] [Abstract][Full Text] [Related]
17. Neutrophils are a main source of circulating suPAR predicting outcome in critical illness.
Gussen H; Hohlstein P; Bartneck M; Warzecha KT; Buendgens L; Luedde T; Trautwein C; Koch A; Tacke F
J Intensive Care; 2019; 7():26. PubMed ID: 31061709
[TBL] [Abstract][Full Text] [Related]
18. Plasma Soluble Urokinase-Type Plasminogen Activator Receptor Level as a Predictor of the Severity of Community-Acquired Pneumonia.
Tsai PK; Tsao SM; Yang WE; Yeh CB; Wang HL; Yang SF
Int J Environ Res Public Health; 2019 Mar; 16(6):. PubMed ID: 30901954
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Role of Circulating Soluble uPAR in Various Cancers: a Systematic Review and Meta-Analysis.
Liu KL; Fan JH; Wu J
Clin Lab; 2017 May; 63(5):871-880. PubMed ID: 28627814
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
